Compare AdaptHealth Corp (AHCO) vs Asana Inc. (ASAN) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

Asana (ASAN) trades at $7.49, up 2.04% with bullish technical momentum and consistent earnings beats. The company shows strong revenue growth from $378M in 2022 to $724M in 2025, though profitability remains negative with a -20.21% net margin. Recent developments include the StackAI acquisition and FedRAMP authorization, positioning Asana in the AI workflow automation space. Analyst consensus is mixed with a $9.86 price target representing 32% upside potential from current levels.

The outlook balances growth potential against persistent losses. Revenue expansion and AI integration offer upside, but negative margins and cash flow volatility present significant execution risks. With the stock trading near analyst targets and mixed institutional sentiment, investors face a high-risk, high-reward scenario requiring careful monitoring of profitability improvements.